oncology innovation

Market Access

New policies are shaping the market access landscape, such as the introduction of the EU HTA for oncology medicines.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.